Volume 18, Number 1—January 2012
CME ACTIVITY - Research
Accelerating Control of Pertussis in England and Wales
Table 2
Variable | No. (%) case-patients, by age group* |
||||
---|---|---|---|---|---|
<1 y, n = 1,185† | 1–4 y, n = 190‡ | 5–9 y, n = 225§ | 10–14 y, n = 498¶ | >15 y, n = 1,781# | |
No. vaccine doses administered before symptom onset | |||||
0 | 840 (77) | 76 (44) | 51 (24) | 38 (8) | 652 (59) |
1 | 196 (18) | 9 (5) | 8 (4) | 6 (1) | 24 (2) |
2 | 36 (3) | 1 (1) | 4 (2) | 7 (1) | 26 (2) |
3 | 24 (2) | 85 (49) | 98 (47) | 419 (86) | 396 (36) |
4 | 0 | 3 (2) | 48 (23) | 15 (3) | 0 |
Total hospitalized | 927 (90) | 66 (42) | 35 (19) | 44 (10) | 81 (5) |
Any complications** | |||||
Yes | 394 (39) | 30 (19) | 22 (12) | 29 (7) | 176 (11) |
Yes, excluding apnea in those >1 y old | 394 (39) | 11 (8) | 19 (11) | 18 (4) | 69 (5) |
*Proportions are based on total cases where these details were provided.
†Median age at onset 53 d; 48% male.
‡Median age at onset 2.5 y; 42% male.
§Median age at onset 7.8 y; 50% male.
¶Median age at onset 12.5 y; 49%male.
#Median age at onset 41.8 y; 44% male.
**Specifically reported pneumonia, convulsion, apnea, conjunctival hemorrhage, or death.
Page created: December 23, 2011
Page updated: December 23, 2011
Page reviewed: December 23, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.